"Visit the UCLA Health website for coronavirus updates."

During the past decade, UCLA Hematology Oncology-Alhambra conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Hematology Oncology-Alhambra" #1 collaborator was "Medivation, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Hematology Oncology-Alhambra" are "Advanced Solid Tumors" (1 trials), "Breast Cancer" (1 trials), "Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "UCLA Hematology Oncology-Alhambra" in a lesser frequency.

Most popular intervention types in "UCLA Hematology Oncology-Alhambra" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Talazoparib" (2 trials), "Active Comparator (erlotinib)" (1 trials), "Dacomitinib (PF-00299804)" (1 trials), "PD 0332991" (1 trials) and "Placebo PF00299804" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Hematology Oncology-Alhambra" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UCLA Hematology Oncology-Alhambra". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in UCLA Hematology Oncology-Alhambra, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Hematology Oncology-Alhambra, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".